Menu Search
Equities

Republic Healthcare Ltd

8357:HKG.HZ

Republic Healthcare Ltd

Actions
  • Price (HKD)0.10
  • Today's Change0.00 / 0.00%
  • Shares traded10.00k
  • 1 Year change-54.13%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Republic Healthcare Limited is a Singapore-based investment holding company. The Company and its subsidiaries are principally engaged in operating medical clinics business in Singapore and provision of management advisory services; pepper trading business, and education related business. The Company's segments include Treatment services, Medical Investigation Services, Consultation services, and Pepper Trading. It operates a network of general practice clinics under the brand Dr. Tan & Partners. The Company provides quality care services for a range of conditions, including sexual health, men’s health and women’s health. Its Medical Investigation Services include laboratory tests, which consists of blood tests, urine tests, stool tests, histopathology and culture and sensitivity tests, and radiology tests, including X-ray, ultrasound scanning, magnetic resonance imaging (MRI) and CT scanning. Its subsidiaries include Republic Healthcare Holdings Ltd, Dtap Clinics Pte. Ltd., and others.

  • Revenue in HKD (TTM)58.07m
  • Net income in HKD-4.96m
  • Incorporated2018
  • Employees37.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.